Item 3.02 Unregistered Sales of Equity Securities. On June 26, 2026, Versus Systems, Inc. (the “Company”) consummated the transactions contemplated by its Stock Purchase Agreement (the “SPA”) with ASPIS Cyber Technologies, Inc. (“ASPIS”), dated April 15, 2026. Specifically, the Company has issued to ASPIS 1,310,969 shares of Company common stock at a per share price of $1.29675 and total consideration of $1,700,000.…
Filed Jun 29, 2026Accepted Jun 29, 2026, 6:25 AM EDTCIK 1701963Accession 0001213900-26-072834
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sales of Equity Securities.
On June 26, 2026, Versus Systems, Inc. (the “Company”)
consummated the transactions contemplated by its Stock Purchase Agreement (the “SPA”) with ASPIS Cyber Technologies, Inc.
(“ASPIS”), dated April 15, 2026. Specifically, the Company has issued to ASPIS 1,310,969 shares of Company common stock at
a per share price of $1.29675 and total consideration of $1,700,000. The SPA was filed as Exhibit 10.1 to the Company’s Form 8-K
filed with the Securities and Exchange Commission on April 15, 2026. The issuance of such shares pursuant to the SPA is exempt from registration
under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
─────────────────────────────────────────────────────────────────────────────────────────────────
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).